SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alchemy Pay

Alchemy Pay (ACH) is trending amid active discussions surrounding its strategic partnerships, including a recent integration with Ripple's RLUSD stablecoin to enhance global fiat on-ramps. The community is also focused on ACH's expanding regulatory footprint with new US Money Transmitter Licenses and the anticipated launch of its stablecoin-centric Alchemy Chain, driving optimism for its future in crypto payments.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending amid strong financial results and an optimistic outlook, fueled by positive clinical trial advancements in HIV, key regulatory approvals for its HIV prevention regimen, and strategic acquisitions diversifying its oncology and antiviral pipeline. The community is actively discussing the company's robust portfolio and extended patent protection for its blockbuster HIV therapies, while also monitoring recent oncology trial setbacks and a notable coverage decision impacting a new offering.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical (DRTS) is a top trending stock, driven by high anticipation for its presentation at the J.P. Morgan Healthcare Conference and the imminent PMDA approval in Japan. The community is buzzing about recent positive clinical data, particularly for pancreatic and skin cancer, which showcases the revolutionary Alpha DaRT technology's potential and is attracting significant institutional interest. This momentum, marked by robust volume and new price levels, underscores investor belief in the company's trajectory within the targeted alpha therapy sector.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending due to its strong community-driven "pure meme" culture, actively spreading its "infection" across the Solana ecosystem. The community expresses high conviction, frequently discussing consistent building, collaborative meme energy with tokens like $CAW, and positioning $PMV for significant growth within an anticipated memecoin season.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is trending amidst significant community excitement fueled by its rumored collaboration with POL and recent integration with ACH, reflecting growing interest in its real-world utility as an OG privacy coin. Investors are actively discussing its potential to experience strong upward momentum, drawing comparisons to recent surges observed in other privacy tokens like Zcash during the broader altcoin season.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending amid growing optimism for its accelerating AWS growth, driven by increasing AI demand and strategic infrastructure investments, which is exciting the community. Investors are keenly watching its expansion in healthcare through Amazon Pharmacy and widely discuss the stock as an undervalued giant poised for a significant upward movement.

Chiliz is a fintech platform for the sports industry to allow global fans to get closer to their favorite sports teams and clubs.

Chiliz

Chiliz (CHZ) is trending amid recent regulatory clarity from MiCA compliance in Europe and strategic expansion into new markets, including K-Pop and integrations with South Korea's Naver Pay. The community is actively discussing its potential for significant growth, fueled by these foundational developments and strong anticipation around the upcoming European Football Championship.

BlackPearl.Chain is pushing decentralization into the future with a third-generation public blockchain. It’s network achieves blazing transaction speeds (Millions TPS) using Sharding and a VRF lightning-fast consensus mechanism built in-house. Finality is achieved in under three seconds with revolutionary P2P, Its speed and security make it the perfect platform for applications like digital asset trading, social media messaging, payment processing, supply chain tracking, and other high-scale use cases.

BlackPearl

The BPLC crypto community is highly optimistic about its long-term potential, with many envisioning it as a future "game changer" in commerce. Enthusiastic investors are comparing it to established digital assets like XRP, eagerly anticipating mainstream exchange adoption and significant market cap expansion.

Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Inspire Medical Systems Inc

Inspire Medical Systems is currently trending following recent positive regulatory news, as CMS finalized a rule to significantly boost reimbursement rates for its sleep apnea procedures starting in 2026, prompting multiple analyst upgrades. This has ignited bullish community sentiment and a notable stock surge, though ongoing discussions still weigh the potential long-term impact of GLP-1 weight loss drugs on the sleep apnea market.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as investors anticipate key clinical data readouts for its retinal disease pipeline in early 2026, especially following positive early results for its KSI-101 program. The community is actively discussing the company's strengthened financial position from a recent upsized public offering, which is seen as de-risking its development strategy and signaling strong institutional confidence in its potential within the multi-billion dollar retinal market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mind Medicine (MindMed) (NASDAQ:MNMD) Sets New 52-Week High - Still a Buy?

Mind Medicine (MindMed) (NASDAQ:MNMD) Hits New 52-Week High - Time to Buy...

Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.8% on Insider Selling

Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 3.8% After Insider Selling...

Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Sells $148,279.40 in Stock

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Mark Sullivan sold 11,276 shares of the firm's stock in a transaction dated Friday, December 26th. The stock was sold at an...

Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Daniel Karlin Sells 5,600 Shares

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Daniel Karlin sold 5,600 shares of the firm's stock in a transaction on Friday, December 26th. The stock was sold at an average...

Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Mark Sullivan Sells 11,276 Shares

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Mark Sullivan sold 11,276 shares of the company's stock in a transaction dated Friday, December 26th. The shares were sold at an...

Mind Medicine (MindMed) (NASDAQ:MNMD) CEO Sells $339,151.65 in Stock

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) CEO Robert Barrow sold 25,791 shares of the business's stock in a transaction dated Friday, December 26th. The shares were sold at an...

Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 3.1% - Should You Buy?

Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 3.1% - What's Next...

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?

MNMD has surged 101% in six months with MM120 advancing in phase III for GAD and MDD. Pivotal readouts are slated for 2026.

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Rating of "Buy" from Analysts

Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have been assigned an average rating of "Buy" from the twelve ratings firms that are currently covering the firm, MarketBeat...

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of "Buy" from Analysts

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has received a consensus rating of "Buy" from the twelve analysts that are presently covering the stock, MarketBeat.com reports. One...

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

MNMD
Mind Medicine Inc - Ordinary Shares (Sub Voting)

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MNMD News

MNMDMind Medicine Inc - Ordinary Shares (Sub Voting)